Cargando…
The Use of Antidiabetic, Antihypertensive, and Lipid-lowering Medications in the Elderly Dying with Advanced Cancer
BACKGROUND: Maintenance of medications that are unconducive to the quality of life is difficult to justify in dying terminally-ill cancer patients. OBJECTIVE: We aimed at determining the prevalence of administering antidiabetic, antihypertensive, and lipid-lowering medications to elderly patients dy...
Autores principales: | Al-Shahri, Mohammad Zafir, Sroor, Mahmoud Yassein, Ghareeb, Wael Ali, Aboulela, Enas Noshy, Edesa, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388588/ https://www.ncbi.nlm.nih.gov/pubmed/30820114 http://dx.doi.org/10.4103/IJPC.IJPC_96_18 |
Ejemplares similares
-
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
por: Tang, Bowen, et al.
Publicado: (2023) -
Antihypertensive Treatment in the Elderly and Very Elderly: Always “the Lower, the Better?”
por: Mazza, Alberto, et al.
Publicado: (2012) -
Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012) -
Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study
por: Rida, Elyamani, et al.
Publicado: (2020) -
Association between dyslipidemia and antihypertensive and antidiabetic treatments in a China multicenter study
por: Miao, Chao‐Ying, et al.
Publicado: (2021)